{"id":"https://openalex.org/W2174407100","doi":null,"title":"Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.","display_name":"Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W2174407100","mag":"2174407100","pmid":"https://pubmed.ncbi.nlm.nih.gov/16898258"},"language":"en","primary_location":{"id":"pmid:16898258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16898258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Belgica","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2174407100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009631036","display_name":"Nadine A. M. E. van der Beek","orcid":"https://orcid.org/0000-0001-9161-3301","observed_orcids":["https://orcid.org/0000-0001-9161-3301"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"N A M E van der Beek","raw_affiliation_strings":["Department of Neurology, Erasmus MC, Rotterdam, The Netherlands. n.beek@erasmusmc.nl","Department of Neurology, Erasmus MC Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Erasmus MC, Rotterdam, The Netherlands. n.beek@erasmusmc.nl","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Neurology, Erasmus MC Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020495820","display_name":"Marloes L. C. Hagemans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M L C Hagemans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006481393","display_name":"van der Ploeg At","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A T van der Ploeg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110102445","display_name":"A. J. J. Reuser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A J J Reuser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037368893","display_name":"Pieter A. van Doorn","orcid":"https://orcid.org/0000-0003-2584-3357","observed_orcids":["https://orcid.org/0000-0003-2584-3357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P A van Doorn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6558,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.88282703,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"106","issue":"2","first_page":"82","last_page":"86"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pompe-disease","display_name":"Pompe disease","score":1.0},{"id":"https://openalex.org/keywords/acid-alpha-glucosidase-deficiency","display_name":"acid alpha-glucosidase deficiency","score":0.9879999756813049},{"id":"https://openalex.org/keywords/enzyme-replacement-therapy","display_name":"enzyme replacement therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/recombinant-human-alpha-glucosidase","display_name":"recombinant human alpha-glucosidase","score":0.9760000109672546},{"id":"https://openalex.org/keywords/metabolic-myopathies","display_name":"metabolic myopathies","score":0.7919999957084656},{"id":"https://openalex.org/keywords/glycogen-accumulation","display_name":"glycogen accumulation","score":0.8669999837875366},{"id":"https://openalex.org/keywords/late-onset-pompe-disease","display_name":"late-onset Pompe disease","score":0.8349999785423279},{"id":"https://openalex.org/keywords/infantile-onset-pompe-disease","display_name":"infantile-onset Pompe disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/proximal-myopathy","display_name":"proximal myopathy","score":0.921999990940094},{"id":"https://openalex.org/keywords/respiratory-failure","display_name":"respiratory failure","score":0.8650000095367432},{"id":"https://openalex.org/keywords/treatment-timing","display_name":"treatment timing","score":0.5450000166893005},{"id":"https://openalex.org/keywords/natural-history-of-disease","display_name":"natural history of disease","score":0.7639999985694885}],"concepts":[{"id":"https://openalex.org/C2779969927","wikidata":"https://www.wikidata.org/wiki/Q916766","display_name":"Enzyme replacement therapy","level":3,"score":0.9441828727722168},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8030273914337158},{"id":"https://openalex.org/C2779546488","wikidata":"https://www.wikidata.org/wiki/Q1753547","display_name":"Hypotonia","level":2,"score":0.7602647542953491},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6752484440803528},{"id":"https://openalex.org/C2776735236","wikidata":"https://www.wikidata.org/wiki/Q1365789","display_name":"Glycogen storage disease type II","level":4,"score":0.645807147026062},{"id":"https://openalex.org/C2777300911","wikidata":"https://www.wikidata.org/wiki/Q692536","display_name":"Myopathy","level":2,"score":0.6180753707885742},{"id":"https://openalex.org/C2779438767","wikidata":"https://www.wikidata.org/wiki/Q112412","display_name":"Congenital myopathy","level":4,"score":0.6113497614860535},{"id":"https://openalex.org/C2776917539","wikidata":"https://www.wikidata.org/wiki/Q1497481","display_name":"Failure to thrive","level":2,"score":0.6034919023513794},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5243815779685974},{"id":"https://openalex.org/C2778264360","wikidata":"https://www.wikidata.org/wiki/Q675010","display_name":"Lysosomal storage disease","level":3,"score":0.4163815379142761},{"id":"https://openalex.org/C2777767895","wikidata":"https://www.wikidata.org/wiki/Q4691924","display_name":"Age of onset","level":3,"score":0.41313743591308594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3776962161064148},{"id":"https://openalex.org/C2779999465","wikidata":"https://www.wikidata.org/wiki/Q2094702","display_name":"Muscle biopsy","level":3,"score":0.15535035729408264},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.08940178155899048}],"mesh":[{"descriptor_ui":"D000520","descriptor_name":"alpha-Glucosidases","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D000520","descriptor_name":"alpha-Glucosidases","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005087","descriptor_name":"Glucan 1,4-alpha-Glucosidase","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D005087","descriptor_name":"Glucan 1,4-alpha-Glucosidase","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006009","descriptor_name":"Glycogen Storage Disease Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006009","descriptor_name":"Glycogen Storage Disease Type II","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D006009","descriptor_name":"Glycogen Storage Disease Type II","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:16898258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16898258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Belgica","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/181d2e43-f1f5-4ed4-97d4-432f83f3d64c","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/181d2e43-f1f5-4ed4-97d4-432f83f3d64c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"van der Beek, N A M E, Hagemans, M, van der Ploeg, A, Reuser, A & van Doorn, P 2006, 'Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy', Acta Neurologica Belgica, vol. 106, pp. 82-86.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/181d2e43-f1f5-4ed4-97d4-432f83f3d64c","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/181d2e43-f1f5-4ed4-97d4-432f83f3d64c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Neurologica Belgica, 106, 82 - 86. Springer-Verlag Italia","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2174407100","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16898258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1508384479","https://openalex.org/W1968719025","https://openalex.org/W1978337429","https://openalex.org/W2001805850","https://openalex.org/W2018278507","https://openalex.org/W2031127035","https://openalex.org/W2034661134","https://openalex.org/W2039207316","https://openalex.org/W2042444909","https://openalex.org/W2045626394","https://openalex.org/W2045817726","https://openalex.org/W2053410151","https://openalex.org/W2075594211","https://openalex.org/W2083572253","https://openalex.org/W2097541847","https://openalex.org/W2106552665","https://openalex.org/W2109581185","https://openalex.org/W2113234876","https://openalex.org/W2138998598","https://openalex.org/W2144392873","https://openalex.org/W2145986851","https://openalex.org/W2152085236","https://openalex.org/W2169690599"],"related_works":["https://openalex.org/W4237558993","https://openalex.org/W2966179753","https://openalex.org/W2095643828","https://openalex.org/W2019168491","https://openalex.org/W2412723576","https://openalex.org/W179563837","https://openalex.org/W2102001470","https://openalex.org/W44413045","https://openalex.org/W2321837384"],"abstract_inverted_index":{"Pompe":[0,56],"disease":[1,4,43,57,76,111,223],"(glycogen":[2],"storage":[3],"type":[5],"II,":[6],"acid":[7,22],"maltase":[8],"deficiency)":[9],"is":[10,58,84,139,199],"a":[11,50,59,125,157],"progressive":[12,127],"metabolic":[13],"myopathy":[14],"caused":[15],"by":[16,86],"deficiency":[17],"of":[18,29,34,53,74,102,109,164,188,205,221,235],"the":[19,35,75,99,110,145,173,183,189,203,218,222,231],"lysosomal":[20],"enzyme":[21],"alpha-glucosidase.":[23],"This":[24],"leads":[25],"to":[26,90,229],"an":[27,45],"accumulation":[28],"glycogen":[30],"in":[31,39,78,117,170,180,202],"various":[32],"tissues":[33],"body,":[36],"most":[37],"notably":[38],"skeletal":[40],"muscle.":[41],"The":[42,70,104,147,191],"has":[44,213],"autosomal":[46],"recessive":[47],"inheritance":[48],"with":[49,130,150,172,182],"predicted":[51],"frequency":[52],"1":[54],":40.000.":[55],"continuous":[60],"spectrum":[61],"but":[62],"for":[63,144],"clinical":[64],"practice":[65],"different":[66],"subtypes":[67],"are":[68,154,195],"recognized.":[69],"classic":[71,174],"infantile":[72,175],"form":[73,108,176,187],"occurs":[77],"infants":[79],"(shortly":[80],"after":[81],"birth)":[82],"and":[83,92,156,208,226,233],"characterized":[85],"generalized":[87],"hypotonia,":[88],"failure":[89],"thrive,":[91],"cardiorespiratory":[93],"failure.":[94,134],"Patients":[95],"usually":[96],"die":[97],"within":[98],"first":[100,148],"year":[101],"life.":[103],"non-classic":[105,184],"or":[106,119,131,185],"late-onset":[107,186],"may":[112],"occur":[113],"at":[114],"any":[115],"age":[116],"childhood":[118],"adulthood.":[120],"It":[121],"presents":[122],"predominantly":[123],"as":[124,142,177,179],"slowly":[126],"proximal":[128],"myopathy,":[129],"without":[132],"respiratory":[133],"Enzyme":[135],"replacement":[136],"therapy":[137,159],"(ERT)":[138],"under":[140],"study":[141],"treatment":[143],"disease.":[146,190],"results":[149,194],"recombinant":[151],"human":[152],"alpha-glucosidase":[153],"promising":[155],"registered":[158],"seems":[160],"near.":[161],"Beneficial":[162],"effects":[163],"ERT":[165,198],"have":[166],"been":[167],"reported":[168],"both":[169],"patients":[171,181],"well":[178],"best":[192],"therapeutic":[193],"achieved":[196],"when":[197],"started":[200],"early":[201],"course":[204,220],"symptom":[206],"development":[207],"before":[209],"irreversible":[210],"muscular":[211],"damage":[212],"occurred.":[214],"Detailed":[215],"knowledge":[216],"about":[217],"natural":[219],"becomes":[224],"more":[225,227],"essential":[228],"determine":[230],"indication":[232],"timing":[234],"treatment.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2174407100","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
